Objective:To investigate the effect of Survivin on neuronal apoptosis in the substantia nigra in a rat model of Parkinson’s disease(PD). Methods:Healthy adult male Sprague Dawley rats were randomly divided into 4 groups:control(n=8);PD(n=8);PD + adenovirus empty vector(n=8);and PD + Survivin(n=8). Following 1 week of model induction,rats from the control and PD group received normal stimulation with no intervention,rats from the PD + adenovirus empty vector group received an empty adenovirus vec-tor injection in the substantia nigra,and rats from the PD + Survivin treatment group received an injection of Survivin adenovirus in the substantia nigra. Behavioral evaluation of spontaneous rotation was performed by injecting apomorphine(APO) every week follow-ing completion of the treatment. Following behavioral testing,brain tissue was collected. Neuronal apoptosis in the substantia nigra was determined by TUNEL staining. qRT-PCR and western blot were used to determine mRNA and protein levels of Caspase 3 and 9,respectively. Results:Compared to the PD + adenovirus empty vector group,the PD + Survivin treatment group exhibited significantly fewer spontaneous rotations following treatment(F=22.315,P=0.000,P=0.000). Compared with the PD group and the PD + adenovirus empty vector group,neuronal apoptosis was signifi-cantly reduced in the PD + Survivin treatment group(F=38.912,P=0.000,P=0.000). Compared with the control group,mRNA expression of Caspase-3 and 9(F=338.429,P=0.000,P=0.000;F=283.352,P=0.000,P=0.000) and protein expression of cleaved Caspase-3 and 9(F=640.262,P=0.000,P=0.000;F=354.210,P=0.000,P=0.000) were significantly decreased. Conclusion:Sur-vivin can inhibit apoptosis in the brain by inhibiting Caspase-3 and -9 at the mRNA and protein expression level in rat model of Parkinson’s disease,resulting in protection against neurodegeneration in the substantia nigra and reduced Parkinson’s disease-related symptoms.